comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
vancomycin pharmaswiss infusioonilahuse pulber
pharmaswiss ceska republika s.r.o. - vankomütsiin - infusioonilahuse pulber - 1000mg 1tk; 1000mg 10tk
vancomycin sandoz 500 mg infusioonilahuse pulber
sandoz pharmaceuticals d.d. - vankomütsiin - infusioonilahuse pulber - 500mg 5tk; 500mg 10tk; 500mg 1tk
vancomycin actavis infusioonilahuse pulber
actavis group ptc ehf. - vankomütsiin - infusioonilahuse pulber - 1000mg 10tk; 1000mg 1tk
vancomycin sandoz 1000 mg infusioonilahuse pulber
sandoz pharmaceuticals d.d. - vankomütsiin - infusioonilahuse pulber - 1000mg 10tk; 1000mg 5tk
vancomycin actavis infusioonilahuse kontsentraadi pulber
actavis group ptc ehf. - vankomütsiin - infusioonilahuse kontsentraadi pulber - 500mg 1tk; 500mg 10tk
vancomycin hospira infusioonilahuse kontsentraadi pulber
hospira uk limited - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 10ml 1tk
vancomycin pfizer infusioonilahuse kontsentraadi pulber
pfizer europe ma eeig - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 10tk; 1000mg 100tk
vancomycin pfizer infusioonilahuse kontsentraadi pulber
pfizer europe ma eeig - vankomütsiin - infusioonilahuse kontsentraadi pulber - 500mg 10tk; 500mg 100tk
vancomycin actavis infusioonilahuse kontsentraadi pulber
actavis group ptc ehf. - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 1000mg 1tk